Top Institutions in Ophthalmology - Retinal Diseases
Institutions leading in retinal disease research, particularly age-related macular degeneration and geographic atrophy, have conducted pivotal phase 3 trials and long-term extension studies using rigorous clinical trial designs and advanced imaging techniques to evaluate novel complement inhibitors like pegcetacoplan.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with extensive experience in age-related macular degeneration and geographic atrophy, contributing to landmark studies on complement inhibition therapies.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with a strong focus on retinal degenerations and leadership in clinical trials evaluating novel therapies for AMD and geographic atrophy.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its translational research in retinal diseases, including AMD, and has contributed significantly to understanding the pathophysiology and treatment of geographic atrophy.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a robust retinal research program with expertise in AMD and geographic atrophy, actively involved in clinical trials assessing complement inhibitors and advanced retinal imaging.
-
#5
California Retina Consultants
San Diego, CA
California Retina Consultants, represented by Dr. Dilsher S. Dhoot, is actively involved in clinical research on pegcetacoplan and geographic atrophy, contributing important long-term data on treatment efficacy and safety.